About Genesis Genetics
Genesis Genetics is a company based in Plymouth (United States) founded in 2004 was acquired by CooperSurgical in April 2016. Genesis Genetics offers products and services including Paragard, Endosee Advance System, LEEP, Milex, and RUMI II. Genesis Genetics operates in a competitive market with competitors including Natera, Inflammatix, BillionToOne, Agendia and Progenity, among others.
- Headquarter Plymouth, United States
- SectorsHealthcare
- Email••••••••
- Website genesisgenetics.org
- Social LinkedIn X Facebook Instagram YouTube
- Acquired by CooperSurgical (Apr 2016)
- Legal Name Coopersurgical, Inc.
- Investors
- Acquired byCooperSurgical
(Apr 2016)
Products & Services of Genesis Genetics
Genesis Genetics offers a comprehensive portfolio of products and services, including Paragard, Endosee Advance System, LEEP, Milex, and RUMI II.
Intrauterine device for long-term birth control.
Hysteroscopy device for office-based uterine evaluations.
Loop electrosurgical excision procedure for cervical issues.
Products for uterine support and office treatments.
Uterine manipulator for surgical procedures.
Self-retaining retractors for gynecological operations.
Device for uterine manipulation in surgeries.
Tool for precise surgical delineation.
Single-use surgical instrument for procedures.
Stapler for wound closure in surgeries.
Apps and channels of Genesis Genetics
its YouTube channel CooperSurgical Fertility Solutions has 57.7K subscribers and 30 videos.
Videos from Genesis Genetics
The most watched videos on Genesis Genetics's YouTube channel, CooperSurgical Fertility Solutions (57.7K subscribers). Click a video to play it here.
More on CooperSurgical Fertility Solutions.
Investors in Genesis Genetics
Genesis Genetics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include CooperSurgical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Offers medical devices for fertility, contraception, and women's health care globally. | 1990 | coopersurgical.com | Trumbull, United States |
Investor details for Genesis Genetics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Genesis Genetics
2 dated milestones of Genesis Genetics across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Genesis Genetics is founded.
- Exit Acquired by CooperSurgical.
Competitors of Genesis Genetics
Genesis Genetics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Natera, Inflammatix, BillionToOne, Agendia and Progenity, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| natera.com | 2004 | Redwood, United States | $152.1M | 3,293 | Developer of cell-free DNA testing for oncology, women’s health, and organ health | |
| inflammatix.com | 2016 | San Francisco, United States | $191.47M | 54 | Provider of diagnostic solutions for systemic infections | |
| billiontoone.com | 2015 | San Francisco, United States | $388.62M | 47 | Provider of cell-free cancer liquid biopsy test | |
| agendia.com | 2003 | Irvine, United States | $123M | 203 | Genomic diagnostic products for cancer treatment are provided. | |
| progenity.com | 2011 | San Diego, United States | $216.63M | 125 | Non-invasive prenatal genomic testing is provided for genetic disorders. | |
| genomedx.com | 2008 | San Diego, United States | $69.75M | 159 | Genomic tests for urologic cancers are developed and commercialized. | |
| sequenom.com | 1994 | San Diego, United States | – | 524 | Noninvasive prenatal testing using cell-free fetal nucleic acids is offered. | |
| affymetrix.com | 1991 | Santa Clara, United States | – | 721 | Provider of technologies for multiplex and simultaneous analysis of biological systems at the cell, protein, and gene level | |
| ariosadx.com | 2008 | San Jose, United States | $67.5M | 246 | Molecular diagnostics for prenatal genetic testing are specialized in. | |
| pictordx.com | 2005 | Auckland, New Zealand | $11.1M | – | Immunodiagnostic products are developed via multiplexed assays. |
Detailed competitors of Genesis Genetics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Genesis Genetics
10 companies that operate in the same segment as Genesis Genetics (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Genesis Genetics
Genesis Genetics was founded in 2004.
Genesis Genetics is headquartered in Plymouth, United States. It is registered at Plymouth, Massachusetts, United States.
Genesis Genetics is a leading global provider of Preimplantation Genetic Diagnosis (PGD) Preimplantation Genetic Screening (PGS) - providing expert laboratory services for many of the most respected in vitro fertilization (IVF) centers across US and throughout the world. Founded by a group of scientists, Genesis Genetics has pioneered the clinical practice of preimplantation testing of embryos for inherited genetic abnormalities. They have a specialist team of genetic counselors, molecular geneticists, physicians and admin staff that are able to work closely with your reproductive doctors. Genesis Genetics has performed thousands of procedures that involve PGD PGS. The company has laboratories across the United States, Brasil, United Kingdom, Jordan, Taiwan, and South Africa.
Genesis Genetics's top competitors include Natera, Inflammatix and BillionToOne.
Genesis Genetics offers Paragard, Endosee Advance System, LEEP, Milex, and 6 more products and services.
Genesis Genetics has 1 investor. Key investors include CooperSurgical.
Genesis Genetics operates through Coopersurgical, Inc..
Yes. Genesis Genetics was acquired by CooperSurgical in April 2016.